Stroke Prevention in Atrial Fibrillation: Latest Clinical Trials and Guidelines

Author： Armaganijan Luciana   Patel Dimpi   Dietrich Cristiano   Morillo Carlos A.  

Publisher： MDPI

E-ISSN： 1424-8247|5|4|384-397

ISSN： 1424-8247

Source： Pharmaceuticals, Vol.5, Iss.4, 2012-04, pp. : 384-397

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Concerns Regarding the Use of Dabigatran for Stroke Prevention in Atrial Fibrillation

By Stöllberger Claudia   Finsterer Josef  

Pharmaceuticals, Vol. 5, Iss. 2, 2012-02 ,pp. : 155-168

MDPI

Access to resources Recommend Favorite

Heart Failure and Atrial Fibrillation: From Basic Science to Clinical Practice

By Ferreira João Pedro   Santos Mário  

International Journal of Molecular Sciences, Vol. 16, Iss. 2, 2015-01 ,pp. : 3133-3147

MDPI

Access to resources Recommend Favorite

Clinical Neuroprotective Drugs for Treatment and Prevention of Stroke

By Kikuchi Kiyoshi   Uchikado Hisaaki   Morioka Motohiro   Murai Yoshinaka   Tanaka Eiichiro  

International Journal of Molecular Sciences, Vol. 13, Iss. 6, 2012-06 ,pp. : 7739-7761

MDPI

Access to resources Recommend Favorite

Newer Anticoagulants for Non-Valvular Atrial Fibrillation

By Harburger Joseph M.   Aronow Wilbert S.  

Pharmaceuticals, Vol. 5, Iss. 5, 2012-05 ,pp. : 469-480

MDPI

Access to resources Recommend Favorite

Safety Monitoring in Clinical Trials

By Yao Bin   Zhu Li   Jiang Qi   Xia H. Amy  

Pharmaceutics, Vol. 5, Iss. 1, 2013-01 ,pp. : 94-106

MDPI

Access to resources Recommend Favorite